The main outcome of the study was the increased rate of preeclampsia and other conditions such as pre-term birth, severe infection, and ICU admission due to COVID-19. The data is significant as it shows us women with preeclampsia should be considered a particularly vulnerable group with regard to the risks posed by COVID-19.
Read the full New Yorker article here.
Exciting times ahead as the second round of data collection started in February 2022 and is now close to publication, so keep an eye out for it!